Howard V. Raff
Nessuna posizione attualmente
Profilo
Dr. Howard V.
Raff was Chief Operating Officer at Aimmune Therapeutics, Inc.
Dr. Raff was previously employed as Adjunct Associate Professor by University of Washington, Chief Operating Officer by APT Pharmaceuticals, Inc., Head-West Coast Operations by Biologics Consulting Group, Inc., a Principal by Bristol-Myers Squibb Co., and a Principal by Genetic Systems Corp.
He received his undergraduate degree from the University of Illinois, a graduate degree from Washington State University, and a doctorate degree from Washington State University.
Precedenti posizioni note di Howard V. Raff
| Società | Posizione | Fine |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Direttore operativo | 31/10/2015 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Genetic Systems Corp. | Corporate Officer/Principal | - |
Biologics Consulting Group, Inc.
 Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Formazione di Howard V. Raff
| Washington State University | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 4 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA. | Health Technology |
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Commercial Services |
| Genetic Systems Corp. |
- Borsa valori
- Insiders
- Howard V. Raff
